Comparison of Two Intermittent Urinary Catheters

Sponsor
Hollister Incorporated (Industry)
Overall Status
Completed
CT.gov ID
NCT01284361
Collaborator
(none)
91
4
2
10
22.8
2.3

Study Details

Study Description

Brief Summary

This is an unblinded, multi-center, randomized, controlled, cross-over study assessing wheel-chair bound, male user preference and catheter characteristics of two intermittent urinary catheters. Subjects enrolled in the study will be randomized to order of catheter use. Individual participation will consist of approximately 1 week of product use. The null hypothesis to be tested is there no difference between catheters.

Condition or Disease Intervention/Treatment Phase
  • Device: 30 cm Intermittent Catheter
  • Device: 40 cm Intermittent Catheter
N/A

Detailed Description

  1. is male and at least 18 years of age.

  2. is self-catheterizing at least 3 times a day.

  3. has been performing catheterizations for at least 2 months.

  4. is wheelchair bound.

  5. is able to use a size 12 or 14 French straight catheter.

  6. is willing and able to follow the study protocol and Investigator's instructions.

  7. is in the opinion of the Investigator, qualified to participate.

Study Design

Study Type:
Interventional
Actual Enrollment :
91 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Official Title:
User Preference Study to Compare a 40cm Intermittent Catheter to a 30cm Intermittent Catheter
Study Start Date :
Oct 1, 2010
Actual Primary Completion Date :
Aug 1, 2011
Actual Study Completion Date :
Aug 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: 30 cm Intermittent Catheter

Intervention was the test of a 30 cm catheter compared to standard commercial 40 cm catheter in a cross-over design.

Device: 30 cm Intermittent Catheter
Randomized cross-over
Other Names:
  • Apogee Intermittent Catheter
  • Active Comparator: 40 cm Intermittent Catheter

    Active comparator 40 cm commercial catheter was compared to experimental 30 cm catheter in a cross-over design.

    Device: 40 cm Intermittent Catheter
    randomized cross-over
    Other Names:
  • Apogee Intermittent Catheter
  • Outcome Measures

    Primary Outcome Measures

    1. Percentage of Participants [1 week]

      Percentage of participants that preferred the 40 cm catheter

    Secondary Outcome Measures

    1. Assessment of Ease of Use Characteristics [1 week]

      Ease of insertion, removal, and control while catheterizing were assessed using a 5 point Likert scale. The numbers recorded are the percentage of the "top" two responses on a 5 point Likert scale. On one scale this includes 1) Very Easy or 2) Easy, on a scale ranging from 1) Very Easy to 5) Very Difficult. On the other scale this includes 1) Strongly Agree or 2) Agree on a scale ranging from 1) Strongly Agree to 5) Strongly Disagree.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • is male and at least 18 years of age

    • is self-catheterizing at least 3 times a day

    • has been performing catheterizations for at least 2 months

    • wheelchair bound

    • is able to use a size 12 or 14 French straight catheter

    • is willing and able to follow the study protocol and Investigator's instructions

    • is, in the opinion of the Investigator, qualified to participate

    Exclusion Criteria:
    • has cognitive impairments that preclude completion of study protocol

    • cannot communicate as determined by the Investigator

    • has an existing medical condition that, in the opinion of the investigator, would interfere with the subject's ability to participate or in the interpretation of the results

    • has a symptomatic urinary tract infection determined by interview

    • has a retracted penis

    • has participated in a study during the previous 30 days involving catheterization

    • has been diagnosed with an enlarged prostate

    • has urethral strictures, false passages, or urethral obstruction

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Shepherd Center and Crawford Research Institute Atlanta Georgia United States 30309-1465
    2 Mark Drug Medical Supply Wheeling Illinois United States 60090
    3 Restored Images Kansas City Missouri United States 64119
    4 Vanderbilt University Nashville Tennessee United States 37235

    Sponsors and Collaborators

    • Hollister Incorporated

    Investigators

    • Study Director: Rita Kaurs, MSHSA MT NMT, Hollister Incorporated

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Hollister Incorporated
    ClinicalTrials.gov Identifier:
    NCT01284361
    Other Study ID Numbers:
    • 4875-I
    First Posted:
    Jan 27, 2011
    Last Update Posted:
    Feb 1, 2017
    Last Verified:
    Dec 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Keywords provided by Hollister Incorporated
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details Recruitment period: October 10, 2010 - July 21 , 2011 types of locations: private vendor, public rehabilitation center, university
    Pre-assignment Detail
    Arm/Group Title Control and Test Crossover
    Arm/Group Description test and control intermittent urinary catheters : randomized cross-over
    Period Title: Overall Study
    STARTED 91
    COMPLETED 82
    NOT COMPLETED 9

    Baseline Characteristics

    Arm/Group Title Control and Test Crossover
    Arm/Group Description test and control intermittent urinary catheters : randomized cross-over
    Overall Participants 82
    Age (Count of Participants)
    <=18 years
    0
    0%
    Between 18 and 65 years
    82
    100%
    >=65 years
    0
    0%
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    38.3
    (11.7)
    Gender (Count of Participants)
    Female
    0
    0%
    Male
    82
    100%
    Region of Enrollment (participants) [Number]
    United States
    82
    100%

    Outcome Measures

    1. Primary Outcome
    Title Percentage of Participants
    Description Percentage of participants that preferred the 40 cm catheter
    Time Frame 1 week

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Control and Test Crossover
    Arm/Group Description Control and test intermittent urinary catheters : randomized cross-over
    Measure Participants 82
    Number [percentage of participants]
    91.5
    111.6%
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Control and Test Crossover
    Comments The sample size of 81 subjects provides a 10.8% margin of error.
    Type of Statistical Test Superiority or Other
    Comments
    Statistical Test of Hypothesis p-Value
    Comments
    Method
    Comments
    Method of Estimation Estimation Parameter Proportion
    Estimated Value 91.5
    Confidence Interval (2-Sided) 95%
    84.5 to 97.5
    Parameter Dispersion Type:
    Value:
    Estimation Comments Seventy five of the 82 subjects (91.5%) preferred the longer commercially available catheter over the experimental 30 cm catheter.
    2. Secondary Outcome
    Title Assessment of Ease of Use Characteristics
    Description Ease of insertion, removal, and control while catheterizing were assessed using a 5 point Likert scale. The numbers recorded are the percentage of the "top" two responses on a 5 point Likert scale. On one scale this includes 1) Very Easy or 2) Easy, on a scale ranging from 1) Very Easy to 5) Very Difficult. On the other scale this includes 1) Strongly Agree or 2) Agree on a scale ranging from 1) Strongly Agree to 5) Strongly Disagree.
    Time Frame 1 week

    Outcome Measure Data

    Analysis Population Description
    82 self-catheterizing wheelchair-using men
    Arm/Group Title Control 40 cm Catheter Test 30 cm Catheter
    Arm/Group Description Commercial gel lubricated 40 cm catheter Test gel lubricated 30 cm catheter identical in all aspects to Control catheter except being 10 cm shorter
    Measure Participants 82 82
    Ease of insertion
    84.65
    103.2%
    67.78
    NaN
    Ease of Removal
    94.85
    115.7%
    86.34
    NaN
    Ease of Catheter Control Upon Urethral Insertion
    86.48
    105.5%
    72.19
    NaN
    Confidence of Complete Bladder Drainage
    84.15
    102.6%
    45.80
    NaN
    Ease of Draining into Receptacle
    87.00
    106.1%
    58.02
    NaN
    Ease of Connecting Urine Bag
    35.68
    43.5%
    31.49
    NaN

    Adverse Events

    Time Frame
    Adverse Event Reporting Description
    Arm/Group Title Control 40 cm Catheter Test 30 cm Catheter
    Arm/Group Description Commercial 40 cm gel lubricated catheter Test 30 cm gel lubricated cather similar in all aspects except 10 cm shorter length as control catheter
    All Cause Mortality
    Control 40 cm Catheter Test 30 cm Catheter
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN)
    Serious Adverse Events
    Control 40 cm Catheter Test 30 cm Catheter
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/91 (0%) 0/91 (0%)
    Other (Not Including Serious) Adverse Events
    Control 40 cm Catheter Test 30 cm Catheter
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/91 (0%) 2/91 (2.2%)
    Renal and urinary disorders
    bleeding 0/91 (0%) 0 1/91 (1.1%) 91
    discomfort 0/91 (0%) 0 1/91 (1.1%) 91

    Limitations/Caveats

    Male catheter users only in USA only.

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    Variable restriction depends on site.

    Results Point of Contact

    Name/Title Malford Cullum PhD/Sr Clin Res Scientist
    Organization Hollister Incorporated
    Phone 847-918-3975
    Email malford.cullum@hollister.com
    Responsible Party:
    Hollister Incorporated
    ClinicalTrials.gov Identifier:
    NCT01284361
    Other Study ID Numbers:
    • 4875-I
    First Posted:
    Jan 27, 2011
    Last Update Posted:
    Feb 1, 2017
    Last Verified:
    Dec 1, 2016